Oxidized LDL and its correlation with lipid profile and oxidative stress biomarkers in young healthy Spanish subjects

Journal of Physiology and Biochemistry

Volumn 66, Issue 3, 2010, Pages 221-227

  Burgos Alves, María Isabel ^a   Avilés Plaza, Francisco ^a   Martínez Tomás, Rebeca ^b   Sánchez Campillo, María ^b   Larqué, Elvira ^b   Pérez Llamas, Francisca ^b   Martínez Hernández, Pedro ^a   Parra Pallarés, Soledad ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

F2 Isoprostanes; Lipid profile; Oxidative stress; Oxidized LDL

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CARBONYL DERIVATIVE; CHOLESTEROL; CREATININE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; URIC ACID; 8-HYDROXY-2'-DEOXYGUANOSINE; ANTIOXIDANT; BIOLOGICAL MARKER; DEOXYGUANOSINE; DRUG DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HUMAN; LIPID ANALYSIS; MALE; NORMAL HUMAN; OXIDATIVE STRESS; REFERENCE VALUE; SPAIN; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; CAUCASIAN; METABOLISM; SEX DIFFERENCE;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; DEOXYGUANOSINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; F2-ISOPROSTANES; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; LIPIDS; LIPOPROTEINS, LDL; MALE; OXIDATIVE STRESS; REFERENCE VALUES; SEX FACTORS; SPAIN; SUPEROXIDE DISMUTASE;

EID: 78349232432     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-010-0028-4     Document Type: Article

References (35)

1. Alcaraz-García MJ, Albaladejo MD, Acevedo C, Olea A, Zamora S, Martínez P, Parra S (2008) Effects of hyperoxia on biomarkers of oxidative stress in closed-circuit oxygen military divers. J Physiol Biochem 64:135-141
2. Calmarza Calmarza P (2008) Lipoproteínas de baja densidad (LDL) oxidadas. Electron J Biomed 3:52-60
3. Cerdá B, Soto C, Albaladejo MD, Martínez P, Sánchez-Gascón F, Tomás-Barberán F, Espín JC (2006) Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebocontrolled trial. Eur J Clin Nutr 60:245-253
4. Cesari M, Kritchevsky SB, Nicklas BJ, Penninx BW, Holvoet P, Koh-Banerjee P, Cummings SR, Harris TB, Newman AB, Pahor M (2005) Lipoprotein peroxidation and mobility limitation: results from the Health, Aging, and Body Composition Study. Arch Intern Med 165:2148-2154
5. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE (2001) Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103:1955-1960
6. Fenollar M, Parra S, Albaladejo MD, Cassinello N (2005) Perfil lipídico y estado oxidativo en pacientes con Enfermedad Vascular Periférica. Anales de cirugía cardíaca y Vascular 11 (3):124-128
7. 2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control. Metabolism 53:1118-1120
8. Galle J, Hansen-Hagge T, Wanner C, Seibold S (2006) Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185:219-226
9. Glass CK, Witztum JL (2001) Atherosclerosis. The road ahead. Cell 104:503-516
10. Holvoet P, Collen D (1998) Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis.Atherosclerosis 137:S33-S38
11. Holvoet P, Vanhaecke J, Janssens S (1998) Van de, W. F.; Collen, D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98:1487-1494
12. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, Collen D, Muls E, Van de WF (2001) Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21:844-848
13. Huang JM, Huang ZX, Zhu W (1998) Mechanism of highdensity lipoprotein subfractions inhibiting copper-catalyzed oxidation of low-density lipoprotein. Clin Biochem 31: 537-543
14. 2-isoprostanes in young healthy children at risk for type 1 diabetes mellitus. Free Radic Biol Med 35:551-557
15. Mackness MI, Abbott C, Arrol S, Durrington PN (1993) The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 294(Pt 3):829-834
16. Mackness MI, Durrington PN, Mackness B (2000) How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 11:383-388
17. Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W (2005) Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112:651-657
18. Metso S, Loimaala A, Mercuri MF, Nenonen A, Vuori I, Oja P, Bond MG, Laine S, Rontu R, Lehtimaki T (2004) Circulating oxidized low-density lipoprotein and common carotid artery intima-media thickness in a random sample of middle-aged men. J Biomed Sci 11:356-361
19. Morrow JD, Minton TA, Mukundan CR, Campbell MD, Zackert WE, Daniel VC et al (1994) Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem 269:4317-4326
20. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM (2004) The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45:993-1007
21. Ozata M, Mergen M, Oktenli C, Aydin A, Sanisoglu SY, Bolu E, Yilmaz MI, Sayal A, Isimer A, Ozdemir IC (2002) Increased oxidative stress and hypozincemia in male obesity. Clin Biochem 35:627-631
22. Parra Pallarés S, Albaladejo Otón MD, Martínez Hernández P (2000) Modificaciones cualitativas de las lipoproteínas. Implicaciones fisiopatológicas. An Med Interna (Madrid) 17:317-323
23. Parthasarathy S, Barnett J, Fong LG (1990) High-density lipoprotein inhibits the oxidative modification of lowdensity lipoprotein. Biochim Biophys Acta 1044:275-283
24. Pincemail J, Siquet J, Chapelle JP, Cheramy-Bien JP, Paulissen G, Chantillon AM, Christiaens G, Gielen J, Limet R, Defraigne JO (2000) [Determination of plasma concentrations of antioxidants, antibodies against oxidized LDL, and homocysteine in a population sample from Liege]. Ann Biol Clin (Paris) 58:177-185
25. Poulsen HE, Prieme H, Loft S (1998) Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev 7:9-16
26. Ruano J, López-Miranda J, Marín C, Gómez P, Moreno JA, Fuentes F, Cortés B, Lozano A, Pérez-Martínez P, Pérez-Jiménez F (2005) La ingesta aguda de un desayuno basado en aceite de oliva con alto contenido en polifenoles mejora la función endotelial en el periodo postpandrial. Nutr Hosp 20:139-149, http://scielo.isciii.es/scielo.php?script=sci-arttext&pid= S0212-16112005000300009&lng=es
27. Scheffer PG, Henry RM, Wever EJ, van Rooij GJ, Bos G, Heine RJ, Dekker JM, Diamant M, Stehouwer CD, Nijpels G, Blankenstein MA, Teerlink T (2004) LDL oxidative modifications in well-or moderately controlled type 2 diabetes. Diabetes/Metab Res Rev 20:298-304
28. Sies H (1985) Oxidative stress: introductory remarks. In: Sies H (ed) Oxidative stress. Academic, New york, pp 1-8
29. Sigurdardottir V, Fagerberg B, Wikstrand J, Schmidt C, Hulthe J (2008) Circulating oxidized LDL is associated with the occurrence of echolucent plaques in the carotid artery in 61-year-old men. Scand J Clin Lab Invest 68:292-297
30. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, Shimamura K, Kimura J, Michishita I, Suzuki T, Nagai R (2000) Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20:2243-2247
31. Tsukahara H (2007) Biomarkers for oxidative stress: clinical application in pediatric medicine. Curr Med Chem 14:339-351
32. Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, Kumon Y, Hashimoto K (2004) Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 53:297-302 (Pubitemid 38684688)
33. Van der Zwan LP, Teerlink T, Dekker JM, Henry RM, Stehouwer CD, Jakobs C, Heine RJ, Scheffer PG (2009) Circulating oxidized LDL: determinants and association with brachial flow-mediated dilation. J Lipid Res 50:342-349
34. Van Tits LJ, van Himbergen TM, Lemmers HL (2006) de, G. J.; Stalenhoef, A. F. Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia. Atherosclerosis 185:307-312
35. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA (1995) Effect of platelet activating factoracetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 95:774-782